Modified Intermediate-Dose Cytarabine Combined with Daunorubicin Induction and Re-Induction Protocol Use in Patients with Acute Myeloid Leukemia Journal title: International Journal of Cancer Management Authors: Mozaffar Aznab, Omid Beiki Subject(s):